Conditions: Cytokine Release Syndrome; Recurrent Multiple Myeloma; Refractory Multiple Myeloma
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Biological: Infliximab; Procedure: Positron Emission Tomography; Biological: Talquetamab; Drug: Teclistamab; Procedure: X-Ray Imaging
Sponsors: Naresh Bumma; Janssen Research & Development, LLC; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
